Clinical Trials Directory

Trials / Completed

CompletedNCT04691193

The Effect of STarT Back Screening Tool

The Effect of STarT Back Screening Tool in Determining Prognosis and Workforce Loss in Patients With Acute-Subacute Low Back Pain and Its Relationship With Kinesiophobia

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to examine the effectiveness of StArt Back Tool test in determining prognosis and loss of workforce in patients presenting with low back pain complaints in the acute-subacute period and to examine the relationship between StArt Back Tool test and kinesophobia.

Detailed description

Low back pain (LBP) is a common disorder that affects about 80% of adults at least once in a period of their life. 10% of low back pain becomes chronic and can affect the quality of life negatively and lead to disability. The STarT-Back-Tool was developed to identify people with poor prognosis, such as difficulty returning to work, loss of work force, disability. It has been reported that it would be beneficial to categorize patients according to their risk levels with this tool and plan treatment in primary care treatment centers. Being able to identify patients with a high probability of becoming chronic in the early period is very important to reduce or prevent disability that may occur. The aim of this study is to examine the effectiveness of StArt Back Tool test in determining prognosis and loss of workforce in patients presenting with low back pain complaints in the acute-subacute period and to examine the relationship between StArt Back Tool test and kinesophobia.

Conditions

Timeline

Start date
2020-07-06
Primary completion
2021-01-01
Completion
2021-02-01
First posted
2020-12-31
Last updated
2021-02-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04691193. Inclusion in this directory is not an endorsement.